Patent ID: 7291611
Filing Date: 2007-11-06
Classification: A61P,C07D

Abstract:
1. A compound of Formula I or a pharmaceutically acceptable salt or prodrug thereof, wherein X is selected from the group consisting of CH, O, N and S Z is selected from the group consisting of CH and N Y is selected from the group consisting of ═O, ═NH and ═S or tautomers thereof; SPU is a spacer unit providing a distance d between Z and N wherein —SPU— is a biradical selected from the group consisting of —(CR wherein n, p, and q are each individually and independently in the range 2 to 5, such as 2, 3 , 4, or 5 and A is absent or an optionally substituted —C N together with R and wherein the heterocylic ring is substituted with one or more substituents R R R R each R